Vanderbilt University Medical Center: World-First Clinical Trial to Help Millions With Penicillin Allergies
July 18, 2023
July 18, 2023
NASHVILLE, Tennessee, July 18 (TNSres) -- Vanderbilt University Medical Center issued the following news:
Penicillin allergy affects more than 25 million people in the United States (up to 1 in 10 Americans) and has been shown to lead to particularly poor health outcomes in pregnant women and surgical patients. It is also a public health threat, leading to antibiotic resistance and infections in hospitalized patients that can be life threatening.
Seventy-five% or more p . . .
Penicillin allergy affects more than 25 million people in the United States (up to 1 in 10 Americans) and has been shown to lead to particularly poor health outcomes in pregnant women and surgical patients. It is also a public health threat, leading to antibiotic resistance and infections in hospitalized patients that can be life threatening.
Seventy-five% or more p . . .